Down syndrome, early cataracts, eye diseases, and beta-amyloid conformers
Down syndrome, early cataracts, eye diseases, and beta-amyloid conformers
批准号:
9893680
负责人:
GEOFFREY A CHANG
金额:
$23.63万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2021-08-31
关键词:
AffinityAgeAlzheimer&aposs DiseaseAmyloidAmyloid ProteinsAmyloid beta-ProteinAmyloid beta-Protein PrecursorAntibodiesBindingBiological AssayBiophysicsBirthBrain DiseasesCataractCharacteristicsChemical StructureChemicalsChimeric ProteinsChromosomesChromosomes, Human, Pair 21Cleaved cellClinicalCollaborationsCommunitiesCongenital chromosomal diseaseDepositionDevelopmentDevicesDiseaseDisease ProgressionDown SyndromeEpithelialEpitopesEvolutionEyeEye diseasesFluorescent ProbesFrequenciesFutureGenesGoalsHealthHistologicHumanImageImmuneImmunohistochemistryIn VitroIndividualIntellectual functioning disabilityInvestigationKineticsLettersLibrariesLinkLongevityMeasuresMethodsMolecular ConformationMusNatureOphthalmologistOxidative StressPathologyPlayProteinsQuaternary Protein StructureReagentReportingResearchResourcesRetinaRetinalRoleSenile PlaquesSpecificityStainsStructureTechnologyTestingTherapeuticTissue SampleTissuesValidationconformerearly onsetimagerimprovedinsightlensmolecular recognitionmonomermouse modelnanobodiesnovelnovel therapeuticspreventprotein oligomer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Down syndrome (DS) is the most common chromosomal disorder with an occurrence of 1 in 700 births. It is, by
far, the leading known cause of intellectual disability. The longevity of DS people has thankfully increased and
several health issues have subsequently emerged, sharing commonality with Alzheimer’s disease (AD). DS is
caused by an additional chromosome to the normal 21st pair (Trisomy 21). Chromosome 21 encodes several
genes contributing to AD; most notably amyloid precursor protein (APP), which is cleaved to form different forms
of beta-amyloid (A). Accumulation of A plaques in the AD brain is one its defining pathologies and A is also
present in the eyes of people with DS. Multiple ocular anomalies, including cataracts, occur at a much higher
frequency starting at younger ages for people with DS. These eye disorders are associated with A, which can
cause oxidative stress and degeneration in the lens epithelial layer.
To carefully understand the contribution and role of A in the eye, we propose to adapt a powerful technology
platform for the discovery of a large panel of nanobodies (Nbs) that can be used as conformer-specific probes
to investigate the histological distribution of A in the eye (retina and lens tissue). These Nbs would allow us to
identify overlooked and potentially rare A oligomeric conformers, which could be important to differentiate
deposits found in DS eyes, perhaps yielding some important insights for AD. Further, some of our Nbs may
sequester and dissolve certain oligomers and aggregates of A, enabling the potential development of novel
therapeutics delivered into the eyes of those with DS and AD. Our specific aims are: (1) discover, produce, and
validate Nbs against different conformations of A protein conformer species and (2) test and validate this panel
of Nbs using eye tissue and lens from AD mouse models recapitulating DS. These Nbs will be valuable reagents
for those studying DS and AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biosynthesis of marine terpenoid natural products
-
批准号:10737210
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2023
-
负责人:GEOFFREY A CHANG
-
依托单位:
Synthetically-evolved and engineered Nanobodies selective for Cb isoforms of PKA
-
批准号:10525796
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2022
-
负责人:GEOFFREY A CHANG
-
依托单位:
Nanobody inhibitors of proton-sensing G protein-coupled receptors
-
批准号:10216432
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10380036
-
项目类别:
-
资助金额:$78.24万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10184466
-
项目类别:
-
资助金额:$75.92万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
Development of low-cost, field-ready nanobodies against snake venom
-
批准号:10255596
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10594973
-
项目类别:
-
资助金额:$75.99万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
Down syndrome, early cataracts, eye diseases, and beta-amyloid conformers
-
批准号:10018872
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2019
-
负责人:GEOFFREY A CHANG
-
依托单位:
Identity, mechanisms and early life impacts of transporter interfering compounds
-
批准号:10179393
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2018
-
负责人:GEOFFREY A CHANG
-
依托单位:
Identity, mechanisms and early life impacts of transporter interfering compounds
-
批准号:10424481
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2018
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure-based optimization of a novel pharmacological chaperone therapy for MPSIIIC
-
批准号:9343249
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2017
-
负责人:GEOFFREY A CHANG
-
依托单位:
Targeting the mitochondrial pyruvate carrier to treat neurodegenerative disease
-
批准号:9262289
-
项目类别:
-
资助金额:$58.41万
-
财政年份:2014
-
负责人:GEOFFREY A CHANG
-
依托单位:
Targeting the mitochondrial pyruvate carrier to treat neurodegenerative disease
-
批准号:8843561
-
项目类别:
-
资助金额:$58.41万
-
财政年份:2014
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8389520
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8707456
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:9115590
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8550059
-
项目类别:
-
资助金额:$17.43万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
GEOFF CHANG PRT-CRYSTALLOGRAPHY OF INTEGRAL MEMBRANE PROTEINS
-
批准号:8362052
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2011
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structural biology and high resolution studies of P-glycoprotein
-
批准号:8536320
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2010
-
负责人:GEOFFREY A CHANG
-
依托单位:
Molecular Organization of the Organic Cation-Proton Exchanger, MATE1
-
批准号:8730620
-
项目类别:
-
资助金额:$47.6万
-
财政年份:2010
-
负责人:GEOFFREY A CHANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: